#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
The Bone Marrow Failure and Myelodysplastic Syndrome (MDS) Program in the Dana-Farber/Boston Children's Cancer and Blood Disorders Center is recognized as one of the nation’s best pediatric treatment and research programs for bone marrow failure, myelodysplastic syndromes (MDS), and related conditions.
Our program has the expertise to diagnose and treat a wide range of disorders, including:
We also specialize in the evaluation of undefined bone marrow failure and MDS disorders and offer cutting edge diagnostic testing and research studies.
Find detailed information on our Bone Marrow Failure and Myelodysplastic Syndrome Program on the Dana-Farber/Boston Children's website.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”